A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

Clinical trial NCT07232576 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07232576
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Patients With Moderately to Severely Active Ulcerative Colitis

Start date: 2025-12-01
Primary completion: 2027-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.